Wireless Implants Market
According to Intent Market Research, the Wireless Implants Market is expected to grow from USD 3.0 billion in 2023 at a CAGR of 18.9% to touch USD 9.9 billion by 2030. The Wireless Implants Market is dominated by key players such as AbbVie Inc., Amgen Inc., AstraZeneca plc, Baxter International Inc., Bayer AG, Bristol Myers Squibb Company, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Pfizer Inc., Roche Holding AG and Teva Pharmaceutical Industries Ltd.